SequelSEC

Lite Strategy, Inc. LITS

Pharmaceutical Preparations · CIK 0001262104 · Fiscal year ends 0630

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2025-06-30
Operating income
-$17.46M
Fiscal year ended 2025-06-30
Free cash flow
Unavailable
Fiscal year ended 2025-06-30

Lite Strategy, Inc. (LITS) reported revenue of $0 and net income of -$15.94M for the fiscal year ended 2025-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Lite Strategy, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Lite Strategy, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-06-30
Revenue$0
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$17.46M
Net income-$15.94M
Research & development$3.92M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$13.53M
Selling & marketingUnavailable

Balance

Lite Strategy, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-06-30
Cash & equivalents$18.01M
Total assets$18.28M
Current assets$18.28M
Total liabilities$1.35M
Current liabilities$1.35M
Total equity incl. NCI$16.93M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$0
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$176.00K

Cash flow

Lite Strategy, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-06-30
Operating cash flow-$20.84M
Capital expendituresUnavailable
Investing cash flow$35.15M
Financing cash flow$0
Net change in cashUnavailable
Stock-based compensation-$144.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$368.00K

Derived

Lite Strategy, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-06-30
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio13.50x
Revenue YoY growth-100.0%
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LITS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-05-13View SEC filing
10-Q · Filed 2026-02-17View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-K · Filed 2025-09-26View SEC filing
10-Q · Filed 2025-05-13View SEC filing
10-Q · Filed 2025-02-12View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.